2025-08-11 - Analysis Report
Okay, here's an analysis of Rocket Lab USA Inc (RKLB) based on the provided data, presented in a concise and informative manner.

## Rocket Lab USA Inc (RKLB) Analysis - August 12, 2025

Rocket Lab USA Inc (RKLB) is a space exploration company providing launch services and space systems.

### 1. Performance vs. S&P 500 (VOO)

*   **RKLB Cumulative Return:** 308.26%
*   **VOO Cumulative Return:** 52.87%
*   **Absolute Spread:** 255.7
*   **Relative Spread:** 85.3 (Indicates that RKLB's performance is in the top percentile relative to its historical range compared to VOO.)

**Analysis:** RKLB has significantly outperformed the S&P 500 over the period. The relative spread indicates that this outperformance is substantial compared to its historical variance.

### 2. Alpha, Beta Analysis

| Year       | CAGR     | MDD   | Alpha    | Beta   | Cap(B) |
| ---------- | -------- | ----- | -------- | ------ | ------ |
| 2020-2022  | -39.0%   | 70.8% | -37.0%   | -0.0   | 1.8    |
| 2021-2023  | 0.0%     | 71.5% | -20.0%   | -0.0   | 2.6    |
| 2022-2024  | 189.0%   | 74.7% | 162.0%   | -0.0   | 12.2   |
| 2023-2025  | 327.0%   | 74.7% | 278.0%   | -0.1   | 21.4   |

**Analysis:** RKLB has demonstrated strong positive alpha in recent periods (2022-2024 and 2023-2025), indicating significant outperformance compared to its benchmark, although the beta has remained near zero.  The CAGR has increased significantly, but the MDD suggests high volatility. The market cap has also seen substantial growth.

### 3. Recent Price Action

*   **Current Price:** $44.69
*   **Previous Close:** $44.21
*   **Change:** 1.09%
*   **5-Day MA:** $44.458
*   **20-Day MA:** $46.268
*   **60-Day MA:** $35.4827

**Analysis:** The current price is above the 5-day moving average but below the 20-day moving average, which may indicate a short-term uptrend facing resistance.  The price is significantly above the 60-day MA, suggesting a longer-term uptrend.  The recent price increase of 1.09% indicates positive momentum.

### 4. Market Risk Indicators & Expected Return

*   **MRI:** 0.3323 (Low Risk)
*   **RSI:** 41.03 (Neutral)
*   **PPO:** -2.2856 (Bearish)
*   **Hybrid Signal:** Cash 69% / Sell 1.6% (27 shares) - Caution
*   **Delta_Previous_Relative_Divergence:** -2.7 (Short-term decrease)
*   **Expected Return:** -4.3% (Long-term underperformance vs. S&P 500)

**Analysis:** The MRI indicates low market risk. The RSI is neutral. The PPO suggests a bearish trend. The Hybrid signal suggests a cautionary approach with a recommendation to hold a significant cash position and reduce a small portion of holdings. The negative expected return suggests potential underperformance relative to the S&P 500 over the long term. The negative change in relative divergence signals short-term price weakness.

### 5. Recent News & Significant Events

*   **Aug 11, 2025:** Major business developments, regulatory changes, or market events.
*   **Aug 9, 2025:** Analyst discussion on recent performance and outlook.
*   **Aug 7, 2025:** Notable stock volatility.
*   **Aug 10, 2025:** Market experts highlighting both risks and opportunities.

**Analysis:** Recent news indicates heightened activity around RKLB, including business developments, analyst discussions, volatility, and mixed opinions from market experts.

### 6. Recent Earnings Analysis

| Date       | EPS   | Revenue      |
| ---------- | ----- | ------------ |
| 2025-08-07 | -0.13 | 0.14 B$      |
| 2025-05-08 | -0.12 | 0.12 B$      |
| 2024-11-12 | -0.1  | 0.10 B$      |
| 2024-08-08 | -0.08 | 0.11 B$      |
| 2025-08-07 | -0.08 | 0.11 B$      |

**Analysis:** RKLB is currently reporting negative EPS. Revenue is generally increasing quarter over quarter, although there was a recent decline in the current quarter.

### 7. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | $0.12B    | 28.76%        |
| 2024-12-31 | $0.13B    | 27.81%        |
| 2024-09-30 | $0.10B    | 26.71%        |
| 2024-06-30 | $0.11B    | 25.56%        |
| 2024-03-31 | $0.09B    | 26.06%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
| ---------- | --------- | --------- |
| 2025-03-31 | $0.43B    | -14.05%   |
| 2024-12-31 | $0.38B    | -13.69%   |
| 2024-09-30 | $0.42B    | -12.37%   |
| 2024-06-30 | $0.46B    | -9.15%    |
| 2024-03-31 | $0.48B    | -9.24%    |

**Analysis:** Revenue has generally been increasing. Profit margin has been relatively stable. Equity has decreased, and the Return on Equity (ROE) is negative, which is consistent with the negative EPS.

### 8. Overall Summary

Rocket Lab (RKLB) has significantly outperformed the S&P 500 historically, but recent indicators suggest a more cautious outlook. While the company shows robust revenue growth and positive alpha, it is not yet profitable. The technical indicators are mixed, with short-term weakness signaled by the PPO and relative divergence, alongside the generally good MRI (low risk). Recent news indicates notable volatility and important events impacting the company. Long-term expected returns are currently negative. It is recommended that investor adopt a cautiously optimistic approach, closely monitoring the company's next earnings report and upcoming news for further insights.
